Explore 10 in-demand jobs that pay over $150,000 and have strong growth potential through 2033, according to data from the Bureau of Labor Statistics.

Hoffmann-La Roche Limited (Roche Canada) is pleased to announce that on January 22, 2026, Health Canada has approved Gazyva® (obinutuzumab) for the treatment of adult patients with active lupus ...